The short version
- Cocaine was cited in more drug poisoning deaths than heroin or morphine for the first time, reflecting a fourfold increase since 2015.
- The overall drug death rate fell slightly to 92.4 per million people, marking the first annual drop since 2012, though totals remain high.
- Significant geographic disparities persist, with northern regions experiencing mortality rates more than double those in London.
Official statistics for England and Wales indicate a historic shift in the landscape of drug-related fatalities. For the first time, cocaine has been identified as the leading single substance linked to drug poisoning deaths, surpassing heroin. This change underscores a dramatic escalation in the prevalence and lethality of cocaine use over the past decade, with figures nearly quadrupling since 2015. While the total number of drug deaths registered in 2025 was 5,519, representing a slight decrease from the previous year, the composition of these fatalities has altered significantly.
The Office for National Statistics reported that cocaine was mentioned in 1,233 death cases, slightly fewer than the prior year but exceeding the 1,210 deaths attributed to heroin or morphine. Despite this specific decline in cocaine-linked fatalities, experts caution against interpreting the drop as a sign of improvement. The current volume of cocaine-related deaths remains roughly four times higher than levels recorded ten years ago. Furthermore, when opiate and opioid drugs are considered collectively, they still account for a higher number of deaths than cocaine alone.
The overall fatality rate fell to 92.4 deaths per million people in 2025, down from 93.9 the previous year. This marks the first annual decline since 2012, offering a rare moment of statistical improvement in a long-term upward trend. However, addiction specialists emphasize that the absolute numbers remain objectively high. Total drug fatalities in England and Wales have approximately doubled since 2012, suggesting that the recent dip may be a fluctuation rather than a reversal of the broader crisis.
A stark regional divide characterizes the current data, with inequality growing between different parts of the country. The rate of drug deaths in the North East is more than twice as high as in London. Formerly industrial areas, including Wales, Yorkshire and the Humber, the North West, and the East Midlands, have seen the steepest increases. These regions, which have suffered from poverty and unemployment since the 1980s, are falling behind while more affluent areas show better outcomes. This polarization highlights how socioeconomic factors continue to drive health disparities.
Ketamine-related deaths have also surged, reaching a record 115 in 2025. This figure is nearly double the count from 2024 and represents a massive increase from just seven fatalities a decade earlier. Experts attribute this rise to lower prices and the normalization of ketamine use. There are increasing reports of young people developing dependencies on the drug, leading to acute health issues such as bladder damage. The rapid growth in ketamine fatalities adds another layer of complexity to the evolving drug crisis.
The changing nature of the drug supply is a critical concern for public health officials and charities. Mike Trace, CEO of the Forward Trust, pointed to the proliferation of potent synthetic opioids known as nitazenes. These substances can be many times more powerful than heroin and have been linked to hundreds of deaths across the UK. Additionally, established drugs like cocaine are becoming purer, which significantly increases the risk of overdose for users who may not anticipate the strength of the supply.
The human cost of these statistics is evident in individual cases, such as that of Anthony Irvin, who died from drug poisoning in Ramsgate in September 2025. His family believes his death resulted from a drug supply contaminated with synthetic opioids. However, delays in blood testing mean they may never receive definitive confirmation. Such uncertainties underscore the challenges families face in understanding the causes of loss and highlight the need for faster, more transparent forensic processes.
While England and Wales saw a slight decrease in overall rates, other parts of the UK experienced worsening trends. National Records of Scotland reported an 11% rise in drug deaths in 2025, marking the worst mortality rate in Europe. Similarly, data from Northern Ireland showed a 7.1% increase in drug-related deaths between the 2021-23 and 2022-24 periods. These divergent trends across the UK nations suggest that localized interventions may be having varying degrees of success, while broader structural issues remain unresolved.
Looking ahead, experts warn that the situation remains precarious. The combination of highly potent synthetic drugs, increased purity of traditional substances, and deep-seated regional inequalities creates a volatile environment. While the slight decline in overall deaths is notable, it does not negate the severity of the ongoing crisis. Continued monitoring and targeted support for the most affected communities will be essential to address the root causes of these fatalities.
Sources behind this briefing
Go to the original reporting
- BBC News↗Cocaine overtakes heroin as leading cause of drug deaths in England and Wales
